These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3709496)

  • 61. Relative sensitivity of 32P-postlabelling of DNA and the autoradiographic UDS assay in the liver of rats exposed to 2-acetylaminofluorene (2AAF).
    Gallagher JE; Shank T; Lewtas J; Lefevre PA; Ashby J
    Mutat Res; 1991 Jun; 252(3):247-57. PubMed ID: 2052005
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe.
    Darroudi F; Meijers CM; Hadjidekova V; Natarajan AT
    Mutagenesis; 1996 Sep; 11(5):425-33. PubMed ID: 8921503
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic activation in isolated rat hepatocytes.
    Casciano DA
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():102-6. PubMed ID: 1366416
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo- in vitro assay for potential carcinogens and mutagens.
    Mirsalis JC; Butterworth BE
    Carcinogenesis; 1980 Jul; 1(7):621-5. PubMed ID: 11219838
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A dual-labeling method to quantify unscheduled DNA synthesis in primary cells.
    Li W; Choy DF; Post JM; Sullivan ME
    J Pharmacol Toxicol Methods; 2008; 57(3):220-6. PubMed ID: 18396065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Changes in levels of ADP-ribose polymers in rat liver during 2-acetylaminofluorene-induced hepatocarcinogenesis.
    Kiehlbauch CC; Kosanke SD; Ringer DP
    Carcinogenesis; 1993 Jul; 14(7):1435-40. PubMed ID: 8330362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver.
    Umemura T; Tokumo K; Sirma H; Gebhardt R; Poirier MC; Williams GM
    Cancer Lett; 1993 Sep; 73(1):1-10. PubMed ID: 8402592
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of effect of furfural on unscheduled DNA synthesis in the in vivo rat and mouse hepatocyte DNA repair assays and in precision-cut human liver slices.
    Lake BG; Edwards AJ; Price RJ; Phillips BJ; Renwick AB; Beamand JA; Adams TB
    Food Chem Toxicol; 2001 Oct; 39(10):999-1011. PubMed ID: 11524138
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of specific DNA adducts in the induction of micronuclei by N-hydroxy-2-acetylaminofluorene in rat liver in vivo.
    van de Poll ML; van der Hulst DA; Tates AD; Mulder GJ; Meerman JH
    Carcinogenesis; 1989 Apr; 10(4):717-22. PubMed ID: 2702720
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
    Zanchetti A; Hansson L; Dahlöf B; Elmfeldt D; Kjeldsen S; Kolloch R; Larochelle P; McInnes GT; Mallion JM; Ruilope L; Wedel H
    J Hypertens; 2001 Jun; 19(6):1149-59. PubMed ID: 11403365
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluorene.
    Mittelstaedt RA; Smith BA; Chen T; Beland FA; Heflich RH
    Mutat Res; 1999 Dec; 431(1):167-73. PubMed ID: 10656495
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives.
    Jacobs MM; Matney TS; Griffin AC
    Cancer Lett; 1977 May; 2(6):319-22. PubMed ID: 324608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction of nucleophiles with the enzymatically-activated carcinogen, N-hydroxy-2-acetylaminofluorene, and with the model ester, N-acetoxy-2-acetylaminofluorene.
    Smith BA; Gutmann HR; Springfield JR
    Carcinogenesis; 1985 Feb; 6(2):271-7. PubMed ID: 3971491
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Another approach to in vivo estimation of genetic damage in humans.
    Pero RW; Mitelman F
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):462-3. PubMed ID: 284361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden.
    Samuelsson O; Wilhelmsen L; Elmfeldt D; Pennert K; Wedel H; Wikstrand J; Berglund G
    J Hypertens; 1985 Apr; 3(2):167-76. PubMed ID: 4020124
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Old patients with hypertension. A 25-year observational study of a geographically defined population (Dalby), aged 67 years at entry.
    Lidfeldt J; Lanke J; Sundquist J; Lindholm LH
    J Intern Med; 1998 Dec; 244(6):469-78. PubMed ID: 9893100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis at the sequence level of mutations induced by the ultimate carcinogen N-acetoxy-N-2-acetylaminofluorene.
    Fuchs RP; Schwartz N; Daune MP
    Environ Health Perspect; 1983 Mar; 49():135-40. PubMed ID: 6339221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The reproducibility of individual estimations in the covalent binding of N-acetoxy-2-acetylaminofluorene to DNA and in the induction of unscheduled DNA synthesis.
    Pero RW; Lund-Pero M
    Mutat Res; 1983 Jun; 120(4):219-24. PubMed ID: 6855791
    [No Abstract]   [Full Text] [Related]  

  • 79. Relationship between the covalent binding of N-acetoxy-2-acetylaminofluorene to DNA and a steroidal esterase activity in human mononuclear leukocytes.
    Lund-Pero M; Pero RW; Miller DG
    Chem Biol Interact; 1988; 66(1-2):13-25. PubMed ID: 3383285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutagenicity-enhancing effect of quercetin on the active metabolites of 2-acetylaminofluorene with mammalian metabolic activation systems.
    Ogawa S; Hirayama T; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1987 Apr; 190(4):241-6. PubMed ID: 3550450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.